Amazon's healthcare services have been steadily growing, with the company expanding its same-day prescription delivery services across multiple U.S. cities and initiating the RxPass, a subscription service for generic medications. Despite these advancements, there is currently no indication that Amazon has ventured into offering pet prescriptions within its Amazon Pharmacy services.
Reports from October 2023 suggested that Amazon was exploring opportunities in the pet medicine market, including potential telehealth services for pets. However, these discussions were not conclusive at the time, and as of now, no public announcements have been made regarding Amazon's entry into providing pet prescriptions. Gizmodo highlighted these considerations, noting the strategic interest without concrete developments.
From the stock market perspective, Amazon.com Inc. is currently trading at $192.7, reflecting a slight increase from the previous day's closing price. The stock opened at $191.4, with an intraday high of $192.8 and low of $188.96. As the company continues to innovate its services, investors and consumers alike keep a close watch on its next moves within the healthcare and broader retail landscapes.